Morphogen and proinflammatory cytokine release kinetics from PRGF-Endoret fibrin scaffolds: Evaluation of the effect of leukocyte inclusion
The potential influence of leukocyte incorporation in the kinetic release of growth factors from platelet‐rich plasma (PRP) may explain the conflicting efficiency of leukocyte platelet‐rich plasma (L‐PRP) scaffolds in tissue regeneration. To assess this hypothesis, leukocyte‐free (PRGF‐Endoret) and...
Saved in:
Published in | Journal of biomedical materials research. Part A Vol. 103; no. 3; pp. 1011 - 1020 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Blackwell Publishing Ltd
01.03.2015
Wiley Subscription Services, Inc |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The potential influence of leukocyte incorporation in the kinetic release of growth factors from platelet‐rich plasma (PRP) may explain the conflicting efficiency of leukocyte platelet‐rich plasma (L‐PRP) scaffolds in tissue regeneration. To assess this hypothesis, leukocyte‐free (PRGF‐Endoret) and L‐PRP fibrin scaffolds were prepared, and both morphogen and proinflammatory cytokine release kinetics were analyzed. Clots were incubated with culture medium to monitor protein release over 8 days. Furthermore, the different fibrin scaffolds were morphologically characterized. Results show that leukocyte‐free fibrin matrices were homogenous while leukocyte‐containing ones were heterogeneous, loose and cellular. Leukocyte incorporation produced a significant increase in the contents of proinflammatory cytokines interleukin (IL)‐1β and IL‐16 but not in the platelet‐derived growth factors release (<1.5‐fold). Surprisingly, the availability of vascular endothelial growth factor suffered an important decrease after 3 days of incubation in the case of L‐PRP matrices. While the release of proinflammatory cytokines was almost absent or very low from PRGF‐Endoret, the inclusion of leukocytes induced a major increase in these cytokines, which was characterized by the presence of a latent period. The PRGF‐Endoret matrices were stable during the 8 days of incubation. The inclusion of leukocytes alters the growth factors release profile and also increased the dose of proinflammatory cytokines. © 2014 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 103A: 1011–1020, 2015. |
---|---|
AbstractList | The potential influence of leukocyte incorporation in the kinetic release of growth factors from platelet-rich plasma (PRP) may explain the conflicting efficiency of leukocyte platelet-rich plasma (L-PRP) scaffolds in tissue regeneration. To assess this hypothesis, leukocyte-free (PRGF-Endoret) and L-PRP fibrin scaffolds were prepared, and both morphogen and proinflammatory cytokine release kinetics were analyzed. Clots were incubated with culture medium to monitor protein release over 8 days. Furthermore, the different fibrin scaffolds were morphologically characterized. Results show that leukocyte-free fibrin matrices were homogenous while leukocyte-containing ones were heterogeneous, loose and cellular. Leukocyte incorporation produced a significant increase in the contents of proinflammatory cytokines interleukin (IL)-1β and IL-16 but not in the platelet-derived growth factors release (<1.5-fold). Surprisingly, the availability of vascular endothelial growth factor suffered an important decrease after 3 days of incubation in the case of L-PRP matrices. While the release of proinflammatory cytokines was almost absent or very low from PRGF-Endoret, the inclusion of leukocytes induced a major increase in these cytokines, which was characterized by the presence of a latent period. The PRGF-Endoret matrices were stable during the 8 days of incubation. The inclusion of leukocytes alters the growth factors release profile and also increased the dose of proinflammatory cytokines. The potential influence of leukocyte incorporation in the kinetic release of growth factors from platelet‐rich plasma (PRP) may explain the conflicting efficiency of leukocyte platelet‐rich plasma (L‐PRP) scaffolds in tissue regeneration. To assess this hypothesis, leukocyte‐free (PRGF‐Endoret) and L‐PRP fibrin scaffolds were prepared, and both morphogen and proinflammatory cytokine release kinetics were analyzed. Clots were incubated with culture medium to monitor protein release over 8 days. Furthermore, the different fibrin scaffolds were morphologically characterized. Results show that leukocyte‐free fibrin matrices were homogenous while leukocyte‐containing ones were heterogeneous, loose and cellular. Leukocyte incorporation produced a significant increase in the contents of proinflammatory cytokines interleukin (IL)‐1β and IL‐16 but not in the platelet‐derived growth factors release (<1.5‐fold). Surprisingly, the availability of vascular endothelial growth factor suffered an important decrease after 3 days of incubation in the case of L‐PRP matrices. While the release of proinflammatory cytokines was almost absent or very low from PRGF‐Endoret, the inclusion of leukocytes induced a major increase in these cytokines, which was characterized by the presence of a latent period. The PRGF‐Endoret matrices were stable during the 8 days of incubation. The inclusion of leukocytes alters the growth factors release profile and also increased the dose of proinflammatory cytokines. © 2014 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 103A: 1011–1020, 2015. The potential influence of leukocyte incorporation in the kinetic release of growth factors from platelet-rich plasma (PRP) may explain the conflicting efficiency of leukocyte platelet-rich plasma (L-PRP) scaffolds in tissue regeneration. To assess this hypothesis, leukocyte-free (PRGF-Endoret) and L-PRP fibrin scaffolds were prepared, and both morphogen and proinflammatory cytokine release kinetics were analyzed. Clots were incubated with culture medium to monitor protein release over 8 days. Furthermore, the different fibrin scaffolds were morphologically characterized. Results show that leukocyte-free fibrin matrices were homogenous while leukocyte-containing ones were heterogeneous, loose and cellular. Leukocyte incorporation produced a significant increase in the contents of proinflammatory cytokines interleukin (IL)-1β and IL-16 but not in the platelet-derived growth factors release (<1.5-fold). Surprisingly, the availability of vascular endothelial growth factor suffered an important decrease after 3 days of incubation in the case of L-PRP matrices. While the release of proinflammatory cytokines was almost absent or very low from PRGF-Endoret, the inclusion of leukocytes induced a major increase in these cytokines, which was characterized by the presence of a latent period. The PRGF-Endoret matrices were stable during the 8 days of incubation. The inclusion of leukocytes alters the growth factors release profile and also increased the dose of proinflammatory cytokines. The potential influence of leukocyte incorporation in the kinetic release of growth factors from platelet-rich plasma (PRP) may explain the conflicting efficiency of leukocyte platelet-rich plasma (L-PRP) scaffolds in tissue regeneration. To assess this hypothesis, leukocyte-free (PRGF-Endoret) and L-PRP fibrin scaffolds were prepared, and both morphogen and proinflammatory cytokine release kinetics were analyzed. Clots were incubated with culture medium to monitor protein release over 8 days. Furthermore, the different fibrin scaffolds were morphologically characterized. Results show that leukocyte-free fibrin matrices were homogenous while leukocyte-containing ones were heterogeneous, loose and cellular. Leukocyte incorporation produced a significant increase in the contents of proinflammatory cytokines interleukin (IL)-1 beta and IL-16 but not in the platelet-derived growth factors release (<1.5-fold). Surprisingly, the availability of vascular endothelial growth factor suffered an important decrease after 3 days of incubation in the case of L-PRP matrices. While the release of proinflammatory cytokines was almost absent or very low from PRGF-Endoret, the inclusion of leukocytes induced a major increase in these cytokines, which was characterized by the presence of a latent period. The PRGF-Endoret matrices were stable during the 8 days of incubation. The inclusion of leukocytes alters the growth factors release profile and also increased the dose of proinflammatory cytokines. copyright 2014 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 103A: 1011-1020, 2015. Abstract The potential influence of leukocyte incorporation in the kinetic release of growth factors from platelet‐rich plasma (PRP) may explain the conflicting efficiency of leukocyte platelet‐rich plasma (L‐PRP) scaffolds in tissue regeneration. To assess this hypothesis, leukocyte‐free (PRGF‐Endoret) and L‐PRP fibrin scaffolds were prepared, and both morphogen and proinflammatory cytokine release kinetics were analyzed. Clots were incubated with culture medium to monitor protein release over 8 days. Furthermore, the different fibrin scaffolds were morphologically characterized. Results show that leukocyte‐free fibrin matrices were homogenous while leukocyte‐containing ones were heterogeneous, loose and cellular. Leukocyte incorporation produced a significant increase in the contents of proinflammatory cytokines interleukin (IL)‐1β and IL‐16 but not in the platelet‐derived growth factors release (<1.5‐fold). Surprisingly, the availability of vascular endothelial growth factor suffered an important decrease after 3 days of incubation in the case of L‐PRP matrices. While the release of proinflammatory cytokines was almost absent or very low from PRGF‐Endoret, the inclusion of leukocytes induced a major increase in these cytokines, which was characterized by the presence of a latent period. The PRGF‐Endoret matrices were stable during the 8 days of incubation. The inclusion of leukocytes alters the growth factors release profile and also increased the dose of proinflammatory cytokines. © 2014 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 103A: 1011–1020, 2015. The potential influence of leukocyte incorporation in the kinetic release of growth factors from platelet-rich plasma (PRP) may explain the conflicting efficiency of leukocyte platelet-rich plasma (L-PRP) scaffolds in tissue regeneration. To assess this hypothesis, leukocyte-free (PRGF-Endoret) and L-PRP fibrin scaffolds were prepared, and both morphogen and proinflammatory cytokine release kinetics were analyzed. Clots were incubated with culture medium to monitor protein release over 8 days. Furthermore, the different fibrin scaffolds were morphologically characterized. Results show that leukocyte-free fibrin matrices were homogenous while leukocyte-containing ones were heterogeneous, loose and cellular. Leukocyte incorporation produced a significant increase in the contents of proinflammatory cytokines interleukin (IL)-1[beta] and IL-16 but not in the platelet-derived growth factors release (<1.5-fold). Surprisingly, the availability of vascular endothelial growth factor suffered an important decrease after 3 days of incubation in the case of L-PRP matrices. While the release of proinflammatory cytokines was almost absent or very low from PRGF-Endoret, the inclusion of leukocytes induced a major increase in these cytokines, which was characterized by the presence of a latent period. The PRGF-Endoret matrices were stable during the 8 days of incubation. The inclusion of leukocytes alters the growth factors release profile and also increased the dose of proinflammatory cytokines. © 2014 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 103A: 1011-1020, 2015. |
Author | Zalduendo, M. M. Prado, R. Alkhraisat, M. H. Orive, G. Anitua, E. |
Author_xml | – sequence: 1 givenname: E. surname: Anitua fullname: Anitua, E. organization: Foundation Eduardo Anitua, Vitoria, Spain – sequence: 2 givenname: M. M. surname: Zalduendo fullname: Zalduendo, M. M. organization: Foundation Eduardo Anitua, Vitoria, Spain – sequence: 3 givenname: R. surname: Prado fullname: Prado, R. organization: Foundation Eduardo Anitua, Vitoria, Spain – sequence: 4 givenname: M. H. surname: Alkhraisat fullname: Alkhraisat, M. H. organization: Foundation Eduardo Anitua, Vitoria, Spain – sequence: 5 givenname: G. surname: Orive fullname: Orive, G. email: gorka.orive@ehu.es organization: Foundation Eduardo Anitua, Vitoria, Spain |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/24890049$$D View this record in MEDLINE/PubMed |
BookMark | eNqNkc1uEzEUhUeoiP7Aij2yxKYSmuC_cWx2bUkCqIWCQCwtx3NNnc7YwZ4B8gy8NA5pu2CBuvK90nc_-egcVnshBqiqpwRPCMb05WrZT8yENZTzB9UBaRpacyWave3MVc2oEvvVYc6rAgvc0EfVPuVSYczVQfX7Iqb1VfwGAZnQonWKPrjO9L0ZYtoguxnitQ-AEnRgMqDtMnibkUuxR5efFvN6FtqYYEDOL5MPKFvjXOza_ArNfphuNIOPAUWHhitA4BzYYbt1MF7Hogfkg-3GXKDH1UNnugxPbt6j6st89vnsTX3-YfH27OS8toJNeb0kuJXYNUIqw7DDrRFAiWkkGAuStkBoW2JKyZhtTCuIc9iQKTZqSSy3LTuqjnfekvb7CHnQvc8Wus4EiGPWRAgluRSc3gfFTEmm-D3Q0hBTjG3R5_-gqzimUDJrMi0ROWNqWqgXO8qmmHMCp9fJ9yZtNMF627wuzWuj_zZf6Gc3znHZQ3vH3lZdALoDfvoONv9z6XenFye31np35PMAv-6OTLrWovy00V_fL_Tl6cfXTC7mGrM_Uj7LEg |
CitedBy_id | crossref_primary_10_1080_09537104_2020_1856361 crossref_primary_10_1002_term_2079 crossref_primary_10_1088_1748_605X_aba086 crossref_primary_10_14202_vetworld_2023_799_810 crossref_primary_10_1186_s40729_019_0166_6 crossref_primary_10_3390_dj10090173 crossref_primary_10_3390_jcm12134512 crossref_primary_10_17116_hirurgia202105172 crossref_primary_10_1007_s00238_015_1116_z crossref_primary_10_1007_s10792_017_0582_7 crossref_primary_10_1016_j_jaad_2019_04_037 crossref_primary_10_1080_09537104_2017_1319046 crossref_primary_10_3390_biom12071002 crossref_primary_10_1016_j_aanat_2017_12_006 crossref_primary_10_1016_j_jaad_2018_11_029 crossref_primary_10_4103_1673_5374_198973 crossref_primary_10_1002_cre2_26 crossref_primary_10_1007_s00238_015_1175_1 crossref_primary_10_3390_ijms25074069 crossref_primary_10_1016_j_repbio_2020_100472 crossref_primary_10_3390_jcm10235711 crossref_primary_10_5321_wjs_v4_i2_39 crossref_primary_10_1016_j_aanat_2021_151853 crossref_primary_10_1080_14712598_2021_1945030 crossref_primary_10_1007_s11420_016_9519_3 crossref_primary_10_2217_rme_2018_0087 crossref_primary_10_1016_j_ijpharm_2018_03_034 crossref_primary_10_1016_j_biomaterials_2021_121205 crossref_primary_10_3389_fphar_2021_606232 crossref_primary_10_1111_wrr_12886 crossref_primary_10_61872_sdj_2024_05_02 crossref_primary_10_1016_j_cveq_2023_06_007 crossref_primary_10_1055_s_0042_1755557 crossref_primary_10_1016_j_jtv_2021_02_011 crossref_primary_10_1038_s41427_021_00297_w crossref_primary_10_1002_jbm_b_34234 crossref_primary_10_1016_j_cyto_2017_06_011 crossref_primary_10_3390_jcm7020013 crossref_primary_10_1016_j_jcyt_2020_02_006 crossref_primary_10_1007_s10856_017_6012_6 crossref_primary_10_1186_s40729_018_0140_8 crossref_primary_10_1111_jocd_12446 crossref_primary_10_25279_sak_541936 crossref_primary_10_1016_j_jos_2016_07_009 crossref_primary_10_1111_jocd_13212 crossref_primary_10_2147_JPR_S210715 crossref_primary_10_1097_DSS_0000000000001049 crossref_primary_10_1002_adhm_201801578 crossref_primary_10_1016_j_msec_2016_12_040 crossref_primary_10_1155_2015_542502 crossref_primary_10_1038_s41536_022_00239_2 crossref_primary_10_1155_2020_8546231 crossref_primary_10_1167_tvst_9_6_22 crossref_primary_10_3390_biomedicines10081991 crossref_primary_10_4274_cjms_2020_1736 crossref_primary_10_1155_2022_8767137 crossref_primary_10_36438_JOST2020007 crossref_primary_10_1517_14712598_2016_1157162 crossref_primary_10_1097_01_ASW_0000604168_62330_c7 crossref_primary_10_1111_clr_12742 crossref_primary_10_1080_14712598_2017_1259409 crossref_primary_10_3390_ijms21010139 crossref_primary_10_1007_s00167_017_4565_z crossref_primary_10_1016_j_jor_2016_10_014 crossref_primary_10_1097_WON_0000000000000451 crossref_primary_10_3390_ijms22020824 crossref_primary_10_1007_s10856_024_06780_4 crossref_primary_10_1007_s40266_023_01040_6 crossref_primary_10_1016_j_tibtech_2020_07_011 crossref_primary_10_1016_j_biomaterials_2018_11_029 crossref_primary_10_1155_2015_179756 crossref_primary_10_1007_s40257_017_0277_x crossref_primary_10_1088_1748_605X_aa8469 crossref_primary_10_1186_s12917_022_03491_2 crossref_primary_10_1097_MD_0000000000010242 crossref_primary_10_3390_app12147250 crossref_primary_10_1080_09537104_2017_1317731 crossref_primary_10_1097_01_ASW_0000464706_42760_fe |
Cites_doi | 10.2165/00007256-200939050-00002 10.1016/j.imbio.2007.09.012 10.1016/S0736-0266(01)00075-4 10.1016/S0736-0266(02)00141-9 10.1001/jama.2009.1986 10.1016/j.arthro.2012.05.011 10.1177/1947603511433181 10.1111/j.1582-4934.2009.00941.x 10.1053/j.oto.2012.01.004 10.1182/blood.V99.8.2997 10.1038/nrrheum.2010.4 10.1002/jlb.67.6.757 10.1302/0301-620X.89B3.18491 10.1007/s00167-012-2043-1 10.1177/0363546512442334 10.1053/j.oto.2011.11.001 10.1016/j.jconrel.2011.07.004 10.4049/jimmunol.176.11.6945 10.1177/03946320110241S215 10.1517/14712598.2012.632765 10.1160/TH09-03-0199 10.1016/S1357-2725(97)00053-8 10.1002/jbm.a.30585 10.1016/j.arthro.2009.08.019 10.1002/term.1721 10.1136/bjsm.2004.011312 10.1016/j.thromres.2007.06.016 10.1111/j.1365-2230.2011.04303.x 10.1177/0363546506294078 10.1146/annurev.immunol.16.1.137 10.1007/s00167-011-1837-x 10.1517/14712598.2011.554813 10.2106/JBJS.L.00019 10.1007/s11926-000-0021-y 10.4049/jimmunol.0803849 10.1016/j.transci.2012.06.017 10.1007/s00167-010-1207-0 10.1177/0363546511404877 10.1177/0363546511417792 10.1177/0363546506288850 10.2174/138920112800624382 10.1002/jor.20519 10.1016/S0016-5085(98)70642-0 10.1096/fasebj.11.1.9034166 10.1097/MBC.0b013e3283424911 10.1002/jor.20278 10.1007/s00402-010-1167-3 10.1016/j.aanat.2013.04.004 10.3109/17453670903350081 10.3899/jrheum.080346 |
ContentType | Journal Article |
Copyright | 2014 Wiley Periodicals, Inc. 2015 Wiley Periodicals, Inc. |
Copyright_xml | – notice: 2014 Wiley Periodicals, Inc. – notice: 2015 Wiley Periodicals, Inc. |
DBID | BSCLL CGR CUY CVF ECM EIF NPM AAYXX CITATION 7QF 7QO 7QQ 7SC 7SE 7SP 7SR 7TA 7TB 7U5 8BQ 8FD F28 FR3 H8D H8G JG9 JQ2 K9. KR7 L7M L~C L~D P64 7X8 7T5 H94 |
DOI | 10.1002/jbm.a.35244 |
DatabaseName | Istex Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef Aluminium Industry Abstracts Biotechnology Research Abstracts Ceramic Abstracts Computer and Information Systems Abstracts Corrosion Abstracts Electronics & Communications Abstracts Engineered Materials Abstracts Materials Business File Mechanical & Transportation Engineering Abstracts Solid State and Superconductivity Abstracts METADEX Technology Research Database ANTE: Abstracts in New Technology & Engineering Engineering Research Database Aerospace Database Copper Technical Reference Library Materials Research Database ProQuest Computer Science Collection ProQuest Health & Medical Complete (Alumni) Civil Engineering Abstracts Advanced Technologies Database with Aerospace Computer and Information Systems Abstracts Academic Computer and Information Systems Abstracts Professional Biotechnology and BioEngineering Abstracts MEDLINE - Academic Immunology Abstracts AIDS and Cancer Research Abstracts |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef Materials Research Database Civil Engineering Abstracts Aluminium Industry Abstracts Technology Research Database Computer and Information Systems Abstracts – Academic Mechanical & Transportation Engineering Abstracts Electronics & Communications Abstracts ProQuest Computer Science Collection Computer and Information Systems Abstracts ProQuest Health & Medical Complete (Alumni) Ceramic Abstracts Materials Business File METADEX Biotechnology and BioEngineering Abstracts Computer and Information Systems Abstracts Professional Aerospace Database Copper Technical Reference Library Engineered Materials Abstracts Biotechnology Research Abstracts Solid State and Superconductivity Abstracts Engineering Research Database Corrosion Abstracts Advanced Technologies Database with Aerospace ANTE: Abstracts in New Technology & Engineering MEDLINE - Academic AIDS and Cancer Research Abstracts Immunology Abstracts |
DatabaseTitleList | MEDLINE - Academic MEDLINE AIDS and Cancer Research Abstracts Materials Research Database CrossRef Materials Research Database |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Engineering |
EISSN | 1552-4965 |
EndPage | 1020 |
ExternalDocumentID | 3879792631 10_1002_jbm_a_35244 24890049 JBMA35244 ark_67375_WNG_PBQD38GF_0 |
Genre | article Journal Article |
GroupedDBID | --- -~X .3N .DC .GA .Y3 05W 0R~ 10A 1L6 1OB 1OC 1ZS 31~ 33P 4.4 4ZD 50Z 51W 51X 52N 52O 52P 52S 52T 52W 52X 53G 5GY 5VS 66C 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A03 AAEVG AAHHS AANLZ AAONW AASGY AAXRX AAZKR ABCQN ABCUV ABEML ABIJN ABJNI ABLJU ACAHQ ACBWZ ACCFJ ACCZN ACGFS ACIWK ACPOU ACPRK ACXBN ACXQS ADEOM ADIZJ ADKYN ADMGS ADOZA ADXAS ADZMN ADZOD AEEZP AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFFNX AFFPM AFGKR AFPWT AFRAH AFZJQ AHBTC AHMBA AITYG AIURR AIWBW AJBDE ALMA_UNASSIGNED_HOLDINGS ALUQN AMBMR AMYDB ATUGU AZBYB AZFZN BAFTC BDRZF BFHJK BROTX BRXPI BSCLL BY8 CO8 CS3 D-E D-F DCZOG DPXWK DR2 DRFUL DRSTM DU5 EBD EBS EJD EMOBN F00 F01 F04 F5P FEDTE G-S G.N GNP GODZA H.T H.X HBH HF~ HGLYW HHY HHZ HVGLF HZ~ J0M JPC KQQ LATKE LAW LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES MEWTI MRFUL MRSTM MSFUL MSSTM MXFUL MXSTM N04 N05 N9A NF~ O9- OIG P2P P2W P2X P4D PQQKQ Q.N QB0 QRW R.K RNS ROL RWI RYL SUPJJ SV3 UB1 V2E W8V W99 WIH WIK WJL WQJ WRC WXSBR XG1 XV2 ZZTAW ~IA ~WT CGR CUY CVF ECM EIF NPM AAYXX CITATION 7QF 7QO 7QQ 7SC 7SE 7SP 7SR 7TA 7TB 7U5 8BQ 8FD F28 FR3 H8D H8G JG9 JQ2 K9. KR7 L7M L~C L~D P64 7X8 7T5 H94 |
ID | FETCH-LOGICAL-c6374-b10d80f5689a30f0da6e21a58eace82de12d0528833c5ad61ff0a170a9b1c4cd3 |
IEDL.DBID | DR2 |
ISSN | 1549-3296 |
IngestDate | Fri Aug 16 01:03:49 EDT 2024 Fri Aug 16 21:11:14 EDT 2024 Fri Aug 16 13:18:33 EDT 2024 Mon Nov 04 11:33:49 EST 2024 Thu Sep 26 17:27:28 EDT 2024 Sat Sep 28 07:54:18 EDT 2024 Sat Aug 24 00:52:10 EDT 2024 Wed Oct 30 09:50:43 EDT 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 3 |
Keywords | leukocytes fibrin scaffold growth factors inflammation platelet-rich plasma |
Language | English |
License | 2014 Wiley Periodicals, Inc. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c6374-b10d80f5689a30f0da6e21a58eace82de12d0528833c5ad61ff0a170a9b1c4cd3 |
Notes | ark:/67375/WNG-PBQD38GF-0 ArticleID:JBMA35244 istex:787FE7CE51885C64A7370BB504F1F924AADAA48E ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
PMID | 24890049 |
PQID | 1737443397 |
PQPubID | 2034572 |
PageCount | 10 |
ParticipantIDs | proquest_miscellaneous_1669848642 proquest_miscellaneous_1660398394 proquest_miscellaneous_1652439334 proquest_journals_1737443397 crossref_primary_10_1002_jbm_a_35244 pubmed_primary_24890049 wiley_primary_10_1002_jbm_a_35244_JBMA35244 istex_primary_ark_67375_WNG_PBQD38GF_0 |
PublicationCentury | 2000 |
PublicationDate | March 2015 |
PublicationDateYYYYMMDD | 2015-03-01 |
PublicationDate_xml | – month: 03 year: 2015 text: March 2015 |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States – name: Mount Laurel |
PublicationTitle | Journal of biomedical materials research. Part A |
PublicationTitleAlternate | J. Biomed. Mater. Res |
PublicationYear | 2015 |
Publisher | Blackwell Publishing Ltd Wiley Subscription Services, Inc |
Publisher_xml | – name: Blackwell Publishing Ltd – name: Wiley Subscription Services, Inc |
References | Sanchez M, Anitua E, Azofra J, Prado R, Muruzabal F, Andia I. Ligamentization of tendon grafts treated with an endogenous preparation rich in growth factors: Gross morphology and histology. Arthroscopy 2010;26:470-480. Del Buono A, Papalia R, Denaro V, Maccauro G, Maffulli N. Platelet rich plasma and tendinopathy: State of the art. Int J Immunopathol Pharmacol 2011;24:79-83. Wu FT, Stefanini MO, Mac Gabhann F, Kontos CD, Annex BH, Popel AS. A systems biology perspective on sVEGFR1: Its biological function, pathogenic role and therapeutic use. J Cell Mol Med 2010;14:528-552. Lard LR, Roep BO, Toes RE, Huizinga TW. Enhanced concentrations of interleukin 16 are associated with joint destruction in patients with rheumatoid arthritis. J Rheumatol 2004;31:35-39. Cruikshank WW, Kornfeld H, Center DM. Interleukin-16. J Leukoc Biol 2000;67:757-766. Gersh KC, Nagaswami C, Weisel JW. Fibrin network structure and clot mechanical properties are altered by incorporation of erythrocytes. Thromb Haemost 2009;102:1169-1175. Archambault J, Tsuzaki M, Herzog W, Banes AJ. Stretch and interleukin-1beta induce matrix metalloproteinases in rabbit tendon cells in vitro. J Orthop Res 2002;20:36-39. Perrin J, Morlon L, Vigneron C, Marchand-Arvier M. Influence of polymorphonuclear leukocytes on the plasma clot formation as evaluated by thromboelastometry (ROTEM). Thromb Res 2008;121:647-652. Bochsen L, Johansson PI, Kristensen AT, Daugaard G, Ostrowski SR. The influence of platelets, plasma and red blood cells on functional haemostatic assays. Blood Coagul Fibrinolysis 2011;22:167-175. Sanchez M, Anitua E, Orive G, Mujika I, Andia I. Platelet-rich therapies in the treatment of orthopaedic sport injuries. Sports Med 2009;39:345-354. Moojen DJ, Everts PA, Schure RM, Overdevest EP, van Zundert A, Knape JT, Castelein RM, Creemers LB, Dhert WJ. Antimicrobial activity of platelet-leukocyte gel against Staphylococcus aureus. J Orthop Res 2008;26:404-410. Bielecki TM, Gazdzik TS, Arendt J, Szczepanski T, Krol W, Wielkoszynski T. Antibacterial effect of autologous platelet gel enriched with growth factors and other active substances: An in vitro study. J Bone Joint Surg Br 2007;89:417-420. Anitua E, Alonso R, Girbau C, Aguirre JJ, Muruzabal F, Orive G. Antibacterial effect of plasma rich in growth factors (PRGF(R)-Endoret(R)) against Staphylococcus aureus and Staphylococcus epidermidis strains. Clin Exp Dermatol 2012;37:652-657. Anitua E, Zalduendo MM, Alkhraisat M, Orive G. Release kinetics of platelet-derived and plasma-derived growth factors from autologous plasma rich in growth factors. Ann Anat 2013;195:461-466. Schuppan D, Schmid M, Somasundaram R, Ackermann R, Ruehl M, Nakamura T, Riecken EO. Collagens in the liver extracellular matrix bind hepatocyte growth factor. Gastroenterology 1998;114:139-152. de Jonge S, de Vos RJ, Weir A, van Schie HT, Bierma-Zeinstra SM, Verhaar JA, Weinans H, Tol JL. One-year follow-up of platelet-rich plasma treatment in chronic Achilles tendinopathy: A double-blind randomized placebo-controlled trial. Am J Sports Med 2011;39:1623-1629. Dragoo JL, Braun HJ, Durham JL, Ridley BA, Odegaard JI, Luong R, Arnoczky SP. Comparison of the acute inflammatory response of two commercial platelet-rich plasma systems in healthy rabbit tendons. Am J Sports Med 2012;40:1274-1281. Blaschke S, Schulz H, Schwarz G, Blaschke V, Muller GA, Reuss-Borst M. Interleukin 16 expression in relation to disease activity in rheumatoid arthritis. J Rheumatol 2001;28:12-21. Anitua E, Sanchez M, Nurden AT, Zalduendo M, de la Fuente M, Orive G, Azofra J, Andia I. Autologous fibrin matrices: A potential source of biological mediators that modulate tendon cell activities. J Biomed Mater Res A 2006;77:285-293. Horstmann WG, Slappendel R, van Hellemondt GG, Wymenga AW, Jack N, Everts PA. Autologous platelet gel in total knee arthroplasty: A prospective randomized study. Knee Surg Sports Traumatol Arthrosc 2011;19:115-121. Filardo G, Kon E, Pereira Ruiz MT, Vaccaro F, Guitaldi R, Di Martino A, Cenacchi A, Fornasari PM, Marcacci M. Platelet-rich plasma intra-articular injections for cartilage degeneration and osteoarthritis: Single- versus double-spinning approach. Knee Surg Sports Traumatol Arthrosc 2012;20:2078-2087. Grenier A, Chollet-Martin S, Crestani B, Delarche C, El Benna J, Boutten A, Andrieu V, Durand G, Gougerot-Pocidalo MA, Aubier M, Dehoux M. Presence of a mobilizable intracellular pool of hepatocyte growth factor in human polymorphonuclear neutrophils. Blood 2002;99:2997-3004. Center DM, Kornfeld H, Cruikshank WW. Interleukin-16. Int J Biochem Cell Biol 1997;29:1231-1234. Anitua E, Sanchez M, Prado R, Orive G. The type of platelet-rich plasma may influence the safety of the approach. Knee Surg Sports Traumatol Arthrosc 2012. DOI: 10.1007/s00167-012-2043-1. de Vos RJ, Weir A, van Schie HT, Bierma-Zeinstra SM, Verhaar JA, Weinans H, Tol JL. Platelet-rich plasma injection for chronic Achilles tendinopathy: A randomized controlled trial. JAMA 2010;303:144-149. Anitua E, Prado R, Azkargorta M, Rodriguez-Suarez E, Iloro I, Casado-Vela J, Elortza F, Orive G. High-throughput proteomic characterization of plasma rich in growth factors (PRGF-Endoret)-derived fibrin clot interactome. J Tissue Eng Regen Med 2013. DOI: 10.1002/term.1721. Sundman EA, Cole BJ, Fortier LA. Growth factor and catabolic cytokine concentrations are influenced by the cellular composition of platelet-rich plasma. Am J Sports Med 2011;39:2135-2140. Bielecki T, Cieslik-Bielecka A, Å»elawski M, Mikusek W. A side-effect induced by the combination of a demineralized freeze-dried bone allograft and leucocyte and platelet-rich plasma during treatment for large bone cysts: A 4-year follow-up clinical study. Transfus Apher Sci 2012;47:133-138. Andia I, Sanchez M, Maffulli N. Joint pathology and platelet-rich plasma therapies. Expert Opin Biol Ther 2012;12:7-22. Tsuzaki M, Guyton G, Garrett W, Archambault JM, Herzog W, Almekinders L, Bynum D, Yang X, Banes AJ. IL-1 beta induces COX2, MMP-1, −3 and −13, ADAMTS-4, IL-1 beta and IL-6 in human tendon cells. J Orthop Res 2003;21:256-264. Andia I, Sanchez M, Maffulli N. Platelet rich plasma therapies for sports muscle injuries: Any evidence behind clinical practice? Expert Opin Biol Ther 2011;11:509-518. Ohnishi T, Kakimoto K, Bandow K, Lowenstein CJ, Daikuhara Y, Matsuguchi T. Mature hepatocyte growth factor/scatter factor on the surface of human granulocytes is released by a mechanism involving activated factor Xa. J Immunol 2006;176:6945-6953. Ludwiczek O, Kaser A, Koch RO, Vogel W, Cruikshank WW, Tilg H. Activation of caspase-3 by interferon alpha causes interleukin-16 secretion but fails to modulate activation induced cell death. Eur Cytokine Netw 2001;12:478-486. Anitua E, Alkhraisat MH, Orive G. Perspectives and challenges in regenerative medicine using plasma rich in growth factors. J Control Release 2012;157:29-38. Sanchez M, Anitua E, Azofra J, Andia I, Padilla S, Mujika I. Comparison of surgically repaired Achilles tendon tears using platelet-rich fibrin matrices. Am J Sports Med 2007;35:245-251. Anitua E, Prado R, Sánchez M, Orive G. Platelet-rich plasma: Preparation and formulation. Oper Tech Orthop 2012;22:25-32. Wang-Saegusa A, Cugat R, Ares O, Seijas R, Cusco X, Garcia-Balletbo M. Infiltration of plasma rich in growth factors for osteoarthritis of the knee short-term effects on function and quality of life. Arch Orthop Trauma Surg 2011;131:311-317. Hamilton B, Knez W, Eirale C, Chalabi H. Platelet enriched plasma for acute muscle injury. Acta Orthop Belg 2010;76:443-448. Peerbooms JC, de Wolf GS, Colaris JW, Bruijn DJ, Verhaar JA. No positive effect of autologous platelet gel after total knee arthroplasty. Acta Orthop 2009;80:557-562. McCarrel TM, Minas T, Fortier LA. Optimization of leukocyte concentration in platelet-rich plasma for the treatment of tendinopathy. J Bone Joint Surg Am 2012;94:e1431-1438. Kisiday JD, McIlwraith CW, Rodkey WG, Frisbie DD, Steadman JR. Effects of platelet-rich plasma composition on anabolic and catabolic activities in equine cartilage and meniscal explants. Cartilage 2012;3:245-254. Wasterlain AS, Braun HJ, Dragoo JL. Contents and formulations of platelet-rich plasma. Oper Tech Orthop 2012;22:33-42. Mishra A, Pavelko T. Treatment of chronic elbow tendinosis with buffered platelet-rich plasma. Am J Sports Med 2006;34:1774-1778. Taipale J, Keski-Oja J. Growth factors in the extracellular matrix. Faseb J 1997;11:51-59. Helming L, Gordon S. The molecular basis of macrophage fusion. Immunobiology 2007;212:785-793. Dohan Ehrenfest DM, Bielecki T, Jimbo R, Barbe G, Del Corso M, Inchingolo F, Sammartino G. Do the fibrin architecture and leukocyte content influence the growth factor release of platelet concentrates? An evidence-based answer comparing a pure platelet-rich plasma (P-PRP) gel and a leukocyte- and platelet-rich fibrin (L-PRF). Curr Pharm Biotechnol 2012;13:1145-1152. Schnabel LV, Mohammed HO, Miller BJ, McDermott WG, Jacobson MS, Santangelo KS, Fortier LA. Platelet rich plasma (PRP) enhances anabolic gene expression patterns in flexor digitorum superficialis tendons. J Orthop Res 2007;25:230-240. Gabay C, Lamacchia C, Palmer G. IL-1 pathways in inflammation and human diseases. Nat Rev Rheumatol 2010;6:232-241. Scott A, Khan KM, Roberts CR, Cook JL, Duronio V. What do we mean by the term "inflammation"? A contemporary basic science update for sports medicine. Br J Sports Med 2004;38:372-380. Sanchez M, Fiz N, Azofra J, Usabiaga J, Aduriz Recalde E, Garcia Gutierrez A, Albillos J, Garate R, Aguirre JJ, Padilla S, Orive G, Anitua E. A randomized clinical trial evaluating plasma rich in growth factors (PRGF-Endoret) versus hyaluronic acid in the short-term treatment of symptomatic knee osteoarthritis. Arthroscopy 2012;28:1070-1078. Kishuku M, Nishioka Y, Abe S, Kishi J, Ogino H, Aono Y, Azuma M, Kinoshita K, Batmunkh R, Makino H, Sone S. Expression of soluble vascular endothelial growth factor receptor-1 in human monocyte-derived mature den 2010; 14 2006; 34 2009; 80 2010; 303 2006; 77 2002; 99 2011; 11 2006; 176 2008; 35 2000; 2 1998; 114 2012; 13 2012; 12 2011; 19 2007; 35 1998; 16 2007; 212 2004; 31 2010; 26 1997; 11 2004; 38 2008; 26 2011; 22 2011; 24 2013; 195 2012; 28 2001; 12 2012; 22 2007; 25 2012; 20 2010; 6 2010; 76 2012 2000; 67 1997; 29 2001; 28 2012; 37 2011; 39 2008; 121 2011; 131 2012; 94 2012; 3 2012; 157 2002; 20 2002; 23 2009; 102 2009; 183 2013 2012; 47 2007; 89 2003; 21 2009; 39 2012; 40 e_1_2_6_53_1 e_1_2_6_32_1 e_1_2_6_30_1 e_1_2_6_19_1 e_1_2_6_13_1 e_1_2_6_36_1 e_1_2_6_11_1 e_1_2_6_34_1 e_1_2_6_17_1 e_1_2_6_55_1 e_1_2_6_15_1 e_1_2_6_38_1 Lard LR (e_1_2_6_51_1) 2004; 31 e_1_2_6_43_1 e_1_2_6_20_1 e_1_2_6_41_1 e_1_2_6_9_1 e_1_2_6_5_1 Blaschke S (e_1_2_6_50_1) 2001; 28 e_1_2_6_7_1 e_1_2_6_24_1 e_1_2_6_3_1 e_1_2_6_22_1 e_1_2_6_28_1 e_1_2_6_45_1 e_1_2_6_26_1 e_1_2_6_47_1 e_1_2_6_52_1 e_1_2_6_54_1 e_1_2_6_10_1 e_1_2_6_31_1 Conti P (e_1_2_6_49_1) 2002; 23 e_1_2_6_14_1 e_1_2_6_35_1 e_1_2_6_33_1 e_1_2_6_18_1 e_1_2_6_39_1 e_1_2_6_56_1 e_1_2_6_16_1 e_1_2_6_37_1 e_1_2_6_42_1 e_1_2_6_21_1 Hamilton B (e_1_2_6_12_1) 2010; 76 e_1_2_6_40_1 e_1_2_6_8_1 e_1_2_6_4_1 e_1_2_6_6_1 e_1_2_6_25_1 e_1_2_6_23_1 Ludwiczek O (e_1_2_6_48_1) 2001; 12 e_1_2_6_2_1 e_1_2_6_29_1 e_1_2_6_44_1 e_1_2_6_27_1 e_1_2_6_46_1 |
References_xml | – volume: 34 start-page: 1774 year: 2006 end-page: 1778 article-title: Treatment of chronic elbow tendinosis with buffered platelet‐rich plasma publication-title: Am J Sports Med – volume: 22 start-page: 167 year: 2011 end-page: 175 article-title: The influence of platelets, plasma and red blood cells on functional haemostatic assays publication-title: Blood Coagul Fibrinolysis – volume: 25 start-page: 230 year: 2007 end-page: 240 article-title: Platelet rich plasma (PRP) enhances anabolic gene expression patterns in flexor digitorum superficialis tendons publication-title: J Orthop Res – volume: 37 start-page: 652 year: 2012 end-page: 657 article-title: Antibacterial effect of plasma rich in growth factors (PRGF(R)‐Endoret(R)) against and strains publication-title: Clin Exp Dermatol – volume: 183 start-page: 8176 year: 2009 end-page: 8185 article-title: Expression of soluble vascular endothelial growth factor receptor‐1 in human monocyte‐derived mature dendritic cells contributes to their antiangiogenic property publication-title: J Immunol – volume: 11 start-page: 509 year: 2011 end-page: 518 article-title: Platelet rich plasma therapies for sports muscle injuries: Any evidence behind clinical practice? publication-title: Expert Opin Biol Ther – volume: 22 start-page: 33 year: 2012 end-page: 42 article-title: Contents and formulations of platelet‐rich plasma publication-title: Oper Tech Orthop – year: 2012 article-title: The type of platelet‐rich plasma may influence the safety of the approach publication-title: Knee Surg Sports Traumatol Arthrosc – volume: 39 start-page: 345 year: 2009 end-page: 354 article-title: Platelet‐rich therapies in the treatment of orthopaedic sport injuries publication-title: Sports Med – volume: 29 start-page: 1231 year: 1997 end-page: 1234 article-title: Interleukin‐16 publication-title: Int J Biochem Cell Biol – volume: 94 start-page: e1431 year: 2012 end-page: 1438 article-title: Optimization of leukocyte concentration in platelet‐rich plasma for the treatment of tendinopathy publication-title: J Bone Joint Surg Am – volume: 6 start-page: 232 year: 2010 end-page: 241 article-title: IL‐1 pathways in inflammation and human diseases publication-title: Nat Rev Rheumatol – volume: 24 start-page: 79 year: 2011 end-page: 83 article-title: Platelet rich plasma and tendinopathy: State of the art publication-title: Int J Immunopathol Pharmacol – volume: 76 start-page: 443 year: 2010 end-page: 448 article-title: Platelet enriched plasma for acute muscle injury publication-title: Acta Orthop Belg – volume: 121 start-page: 647 year: 2008 end-page: 652 article-title: Influence of polymorphonuclear leukocytes on the plasma clot formation as evaluated by thromboelastometry (ROTEM) publication-title: Thromb Res – volume: 39 start-page: 1623 year: 2011 end-page: 1629 article-title: One‐year follow‐up of platelet‐rich plasma treatment in chronic Achilles tendinopathy: A double‐blind randomized placebo‐controlled trial publication-title: Am J Sports Med – volume: 80 start-page: 557 year: 2009 end-page: 562 article-title: No positive effect of autologous platelet gel after total knee arthroplasty publication-title: Acta Orthop – volume: 2 start-page: 459 year: 2000 end-page: 465 article-title: Osteoarthritis and cartilage: The role of cytokines publication-title: Curr Rheumatol Rep – volume: 102 start-page: 1169 year: 2009 end-page: 1175 article-title: Fibrin network structure and clot mechanical properties are altered by incorporation of erythrocytes publication-title: Thromb Haemost – volume: 35 start-page: 245 year: 2007 end-page: 251 article-title: Comparison of surgically repaired Achilles tendon tears using platelet‐rich fibrin matrices publication-title: Am J Sports Med – volume: 23 start-page: 103 year: 2002 end-page: 108 article-title: Interleukin‐16 network in inflammation and allergy publication-title: Allergy Asthma Proc – volume: 77 start-page: 285 year: 2006 end-page: 293 article-title: Autologous fibrin matrices: A potential source of biological mediators that modulate tendon cell activities publication-title: J Biomed Mater Res A – volume: 21 start-page: 256 year: 2003 end-page: 264 article-title: IL‐1 beta induces COX2, MMP‐1, −3 and −13, ADAMTS‐4, IL‐1 beta and IL‐6 in human tendon cells publication-title: J Orthop Res – volume: 11 start-page: 51 year: 1997 end-page: 59 article-title: Growth factors in the extracellular matrix publication-title: Faseb J – volume: 39 start-page: 2135 year: 2011 end-page: 2140 article-title: Growth factor and catabolic cytokine concentrations are influenced by the cellular composition of platelet‐rich plasma publication-title: Am J Sports Med – volume: 38 start-page: 372 year: 2004 end-page: 380 article-title: What do we mean by the term "inflammation"? A contemporary basic science update for sports medicine publication-title: Br J Sports Med – volume: 26 start-page: 470 year: 2010 end-page: 480 article-title: Ligamentization of tendon grafts treated with an endogenous preparation rich in growth factors: Gross morphology and histology publication-title: Arthroscopy – volume: 47 start-page: 133 year: 2012 end-page: 138 article-title: A side‐effect induced by the combination of a demineralized freeze‐dried bone allograft and leucocyte and platelet‐rich plasma during treatment for large bone cysts: A 4‐year follow‐up clinical study publication-title: Transfus Apher Sci – year: 2013 article-title: High‐throughput proteomic characterization of plasma rich in growth factors (PRGF‐Endoret)‐derived fibrin clot interactome publication-title: J Tissue Eng Regen Med – volume: 22 start-page: 25 year: 2012 end-page: 32 article-title: Platelet‐rich plasma: Preparation and formulation publication-title: Oper Tech Orthop – volume: 31 start-page: 35 year: 2004 end-page: 39 article-title: Enhanced concentrations of interleukin 16 are associated with joint destruction in patients with rheumatoid arthritis publication-title: J Rheumatol – volume: 157 start-page: 29 year: 2012 end-page: 38 article-title: Perspectives and challenges in regenerative medicine using plasma rich in growth factors publication-title: J Control Release – volume: 20 start-page: 36 year: 2002 end-page: 39 article-title: Stretch and interleukin‐1beta induce matrix metalloproteinases in rabbit tendon cells in vitro publication-title: J Orthop Res – volume: 19 start-page: 115 year: 2011 end-page: 121 article-title: Autologous platelet gel in total knee arthroplasty: A prospective randomized study publication-title: Knee Surg Sports Traumatol Arthrosc – volume: 3 start-page: 245 year: 2012 end-page: 254 article-title: Effects of platelet‐rich plasma composition on anabolic and catabolic activities in equine cartilage and meniscal explants publication-title: Cartilage – volume: 40 start-page: 1274 year: 2012 end-page: 1281 article-title: Comparison of the acute inflammatory response of two commercial platelet‐rich plasma systems in healthy rabbit tendons publication-title: Am J Sports Med – volume: 99 start-page: 2997 year: 2002 end-page: 3004 article-title: Presence of a mobilizable intracellular pool of hepatocyte growth factor in human polymorphonuclear neutrophils publication-title: Blood – volume: 28 start-page: 1070 year: 2012 end-page: 1078 article-title: A randomized clinical trial evaluating plasma rich in growth factors (PRGF‐Endoret) versus hyaluronic acid in the short‐term treatment of symptomatic knee osteoarthritis publication-title: Arthroscopy – volume: 67 start-page: 757 year: 2000 end-page: 766 article-title: Interleukin‐16 publication-title: J Leukoc Biol – volume: 14 start-page: 528 year: 2010 end-page: 552 article-title: A systems biology perspective on sVEGFR1: Its biological function, pathogenic role and therapeutic use publication-title: J Cell Mol Med – volume: 89 start-page: 417 year: 2007 end-page: 420 article-title: Antibacterial effect of autologous platelet gel enriched with growth factors and other active substances: An in vitro study publication-title: J Bone Joint Surg Br – volume: 26 start-page: 404 year: 2008 end-page: 410 article-title: Antimicrobial activity of platelet–leukocyte gel against Staphylococcus aureus publication-title: J Orthop Res – volume: 12 start-page: 7 year: 2012 end-page: 22 article-title: Joint pathology and platelet‐rich plasma therapies publication-title: Expert Opin Biol Ther – volume: 114 start-page: 139 year: 1998 end-page: 152 article-title: Collagens in the liver extracellular matrix bind hepatocyte growth factor publication-title: Gastroenterology – volume: 303 start-page: 144 year: 2010 end-page: 149 article-title: Platelet‐rich plasma injection for chronic Achilles tendinopathy: A randomized controlled trial publication-title: JAMA – volume: 195 start-page: 461 year: 2013 end-page: 466 article-title: Release kinetics of platelet‐derived and plasma‐derived growth factors from autologous plasma rich in growth factors publication-title: Ann Anat – volume: 28 start-page: 12 year: 2001 end-page: 21 article-title: Interleukin 16 expression in relation to disease activity in rheumatoid arthritis publication-title: J Rheumatol – volume: 176 start-page: 6945 year: 2006 end-page: 6953 article-title: Mature hepatocyte growth factor/scatter factor on the surface of human granulocytes is released by a mechanism involving activated factor Xa publication-title: J Immunol – volume: 13 start-page: 1145 year: 2012 end-page: 1152 article-title: Do the fibrin architecture and leukocyte content influence the growth factor release of platelet concentrates? An evidence‐based answer comparing a pure platelet‐rich plasma (P‐PRP) gel and a leukocyte‐ and platelet‐rich fibrin (L‐PRF) publication-title: Curr Pharm Biotechnol – volume: 212 start-page: 785 year: 2007 end-page: 793 article-title: The molecular basis of macrophage fusion publication-title: Immunobiology – volume: 20 start-page: 2078 year: 2012 end-page: 2087 article-title: Platelet‐rich plasma intra‐articular injections for cartilage degeneration and osteoarthritis: Single‐ versus double‐spinning approach publication-title: Knee Surg Sports Traumatol Arthrosc – volume: 35 start-page: 2306 year: 2008 end-page: 2312 article-title: The interleukin 1beta pathway in the pathogenesis of osteoarthritis publication-title: J Rheumatol – volume: 12 start-page: 478 year: 2001 end-page: 486 article-title: Activation of caspase‐3 by interferon alpha causes interleukin‐16 secretion but fails to modulate activation induced cell death publication-title: Eur Cytokine Netw – volume: 131 start-page: 311 year: 2011 end-page: 317 article-title: Infiltration of plasma rich in growth factors for osteoarthritis of the knee short‐term effects on function and quality of life publication-title: Arch Orthop Trauma Surg – volume: 16 start-page: 137 year: 1998 end-page: 161 article-title: Regulation of immune responses by TGF‐beta publication-title: Annu Rev Immunol – ident: e_1_2_6_14_1 doi: 10.2165/00007256-200939050-00002 – ident: e_1_2_6_34_1 doi: 10.1016/j.imbio.2007.09.012 – ident: e_1_2_6_43_1 doi: 10.1016/S0736-0266(01)00075-4 – ident: e_1_2_6_44_1 doi: 10.1016/S0736-0266(02)00141-9 – ident: e_1_2_6_21_1 doi: 10.1001/jama.2009.1986 – ident: e_1_2_6_8_1 doi: 10.1016/j.arthro.2012.05.011 – ident: e_1_2_6_26_1 doi: 10.1177/1947603511433181 – ident: e_1_2_6_40_1 doi: 10.1111/j.1582-4934.2009.00941.x – ident: e_1_2_6_15_1 doi: 10.1053/j.oto.2012.01.004 – ident: e_1_2_6_35_1 doi: 10.1182/blood.V99.8.2997 – ident: e_1_2_6_41_1 doi: 10.1038/nrrheum.2010.4 – ident: e_1_2_6_47_1 doi: 10.1002/jlb.67.6.757 – ident: e_1_2_6_52_1 doi: 10.1302/0301-620X.89B3.18491 – ident: e_1_2_6_55_1 doi: 10.1007/s00167-012-2043-1 – ident: e_1_2_6_24_1 doi: 10.1177/0363546512442334 – ident: e_1_2_6_56_1 doi: 10.1053/j.oto.2011.11.001 – ident: e_1_2_6_13_1 doi: 10.1016/j.jconrel.2011.07.004 – ident: e_1_2_6_38_1 doi: 10.4049/jimmunol.176.11.6945 – ident: e_1_2_6_4_1 doi: 10.1177/03946320110241S215 – ident: e_1_2_6_10_1 doi: 10.1517/14712598.2012.632765 – ident: e_1_2_6_29_1 doi: 10.1160/TH09-03-0199 – ident: e_1_2_6_46_1 doi: 10.1016/S1357-2725(97)00053-8 – ident: e_1_2_6_31_1 doi: 10.1002/jbm.a.30585 – ident: e_1_2_6_7_1 doi: 10.1016/j.arthro.2009.08.019 – ident: e_1_2_6_3_1 doi: 10.1002/term.1721 – volume: 76 start-page: 443 year: 2010 ident: e_1_2_6_12_1 article-title: Platelet enriched plasma for acute muscle injury publication-title: Acta Orthop Belg contributor: fullname: Hamilton B – ident: e_1_2_6_18_1 doi: 10.1136/bjsm.2004.011312 – ident: e_1_2_6_32_1 doi: 10.1016/j.thromres.2007.06.016 – volume: 23 start-page: 103 year: 2002 ident: e_1_2_6_49_1 article-title: Interleukin‐16 network in inflammation and allergy publication-title: Allergy Asthma Proc contributor: fullname: Conti P – ident: e_1_2_6_54_1 doi: 10.1111/j.1365-2230.2011.04303.x – ident: e_1_2_6_6_1 doi: 10.1177/0363546506294078 – ident: e_1_2_6_33_1 doi: 10.1146/annurev.immunol.16.1.137 – volume: 31 start-page: 35 year: 2004 ident: e_1_2_6_51_1 article-title: Enhanced concentrations of interleukin 16 are associated with joint destruction in patients with rheumatoid arthritis publication-title: J Rheumatol contributor: fullname: Lard LR – ident: e_1_2_6_25_1 doi: 10.1007/s00167-011-1837-x – ident: e_1_2_6_11_1 doi: 10.1517/14712598.2011.554813 – volume: 12 start-page: 478 year: 2001 ident: e_1_2_6_48_1 article-title: Activation of caspase‐3 by interferon alpha causes interleukin‐16 secretion but fails to modulate activation induced cell death publication-title: Eur Cytokine Netw contributor: fullname: Ludwiczek O – ident: e_1_2_6_16_1 doi: 10.2106/JBJS.L.00019 – ident: e_1_2_6_45_1 doi: 10.1007/s11926-000-0021-y – ident: e_1_2_6_39_1 doi: 10.4049/jimmunol.0803849 – ident: e_1_2_6_27_1 doi: 10.1016/j.transci.2012.06.017 – ident: e_1_2_6_22_1 doi: 10.1007/s00167-010-1207-0 – ident: e_1_2_6_20_1 doi: 10.1177/0363546511404877 – ident: e_1_2_6_19_1 doi: 10.1177/0363546511417792 – ident: e_1_2_6_5_1 doi: 10.1177/0363546506288850 – ident: e_1_2_6_30_1 doi: 10.2174/138920112800624382 – ident: e_1_2_6_53_1 doi: 10.1002/jor.20519 – volume: 28 start-page: 12 year: 2001 ident: e_1_2_6_50_1 article-title: Interleukin 16 expression in relation to disease activity in rheumatoid arthritis publication-title: J Rheumatol contributor: fullname: Blaschke S – ident: e_1_2_6_36_1 doi: 10.1016/S0016-5085(98)70642-0 – ident: e_1_2_6_37_1 doi: 10.1096/fasebj.11.1.9034166 – ident: e_1_2_6_28_1 doi: 10.1097/MBC.0b013e3283424911 – ident: e_1_2_6_17_1 doi: 10.1002/jor.20278 – ident: e_1_2_6_9_1 doi: 10.1007/s00402-010-1167-3 – ident: e_1_2_6_2_1 doi: 10.1016/j.aanat.2013.04.004 – ident: e_1_2_6_23_1 doi: 10.3109/17453670903350081 – ident: e_1_2_6_42_1 doi: 10.3899/jrheum.080346 |
SSID | ssj0026052 |
Score | 2.4728167 |
Snippet | The potential influence of leukocyte incorporation in the kinetic release of growth factors from platelet‐rich plasma (PRP) may explain the conflicting... The potential influence of leukocyte incorporation in the kinetic release of growth factors from platelet-rich plasma (PRP) may explain the conflicting... Abstract The potential influence of leukocyte incorporation in the kinetic release of growth factors from platelet‐rich plasma (PRP) may explain the... |
SourceID | proquest crossref pubmed wiley istex |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 1011 |
SubjectTerms | Cell Adhesion Culture Cytokines Cytokines - metabolism Epidermal Growth Factor - metabolism Fibrin Fibrin - chemistry fibrin scaffold Growth factors Hepatocyte Growth Factor - metabolism Humans Hydrogels - chemistry Inclusions Inflammation Insulin - metabolism Insulin-Like Growth Factor I - metabolism Intercellular Signaling Peptides and Proteins - metabolism Interleukin-16 - metabolism Interleukin-1beta - metabolism Leukocytes Leukocytes - cytology Monitors Optics and Photonics Platelet-Derived Growth Factor - metabolism platelet-rich plasma Platelet-Rich Plasma - metabolism Scaffolds Tissue Engineering - methods Transforming Growth Factor beta1 - metabolism Vascular Endothelial Growth Factor A - metabolism |
Title | Morphogen and proinflammatory cytokine release kinetics from PRGF-Endoret fibrin scaffolds: Evaluation of the effect of leukocyte inclusion |
URI | https://api.istex.fr/ark:/67375/WNG-PBQD38GF-0/fulltext.pdf https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fjbm.a.35244 https://www.ncbi.nlm.nih.gov/pubmed/24890049 https://www.proquest.com/docview/1737443397 https://search.proquest.com/docview/1652439334 https://search.proquest.com/docview/1660398394 https://search.proquest.com/docview/1669848642 |
Volume | 103 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELZQucCB9yNQkJEqLijbOLYTh1tLd7eqtFWpqOjNcmJHgt0mqEkk4MQfQOI38kuYcdLQIrQS3BJlovgxk_lsz3xDyFYKPiy2TILyOum3bkIlnQitM6Uz4AAZx9zhxWGyfyIOTuXpEJuDuTA9P8S44YaW4f_XaOAmb7Z_k4Z-zM8mZgL4QSAbKOMpBnTtHY_kUQjU_VknrIBCHmfJkJ0HT7YvvXvFH13Hof38N7B5Fbt65zO73VdYbTxnIcacLCddm0-Kr38wOv53v-6QWwMspTu9Ht0l11x1j9y8RFZ4n3xf1DAnNSgcNZWl0BZQTtCnM39OT4svbb0EaYpVWMA1UrxBDmiKGSz06Hg--_ntx7TCyiYtLTHToKJNYcqyXtnmNZ2OtOO0LinAUtqHmuDdynXLGj7g6IeqWHW4wfeAnMym797sh0Mxh7BIeCrCnEVWRaVMVGZ4VEbWJC5mRir48zsVW8diCxOGtY8LaWzCyjIyLI1MlrNCFJY_JBtVXbnHhAKiABSUS4Pk99BMI1Ll4lg5a1hZRHlAti6mVH_qOTt0z84caxhdbbQf3YC89NM9ypjzJYa5pVK_P5zro923e1zNZzoKyOaFPujBwhvNQFAIDtockBfjY7BNPHAxlas7kEngOzzjXKyTSSKeAUxdL5MpoWCpGJBHvT6OjY6FynCZF5BXXqvW9Vgf7C52_NWTf5J-Sm4ATpQYesfkJtlozzv3DLBYmz_3JvcLVlsxSQ |
link.rule.ids | 315,783,787,1378,27936,27937,46306,46730 |
linkProvider | Wiley-Blackwell |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELagPQAH3o9AASNVXFC2cewkDreW7oPSXZWqVXuznNiRYLcJ6m4k4MQfQOI38kuYcbKhRWgluCXKRPFjJvN57PmGkM0EfFhoWATKayMXuvFlZIVvrC6sBgfIOOYOjyfx6FjsnUanbcANc2Eafogu4IaW4f7XaOAYkN76zRr6MTvr6R4ACCGuknUweI6lG3YPO_oohOputxPWQD4P07jNz4MnWxdevuSR1nFwP_8Nbl5Gr879DG4RtWx4c-pk2qsXWS__-gen4__37Da52SJTut2o0h1yxZZ3yY0LfIX3yPdxBdNSgc5RXRoKjQH9BJU6c1v1NP-yqKYgTbEQC3hHijdIA00xiYUeHA4HP7_96JdY3GRBC0w2KOk810VRzcz8Ne13zOO0KiggU9qcNsG7ma2nFXzA0g9lPqsxxnefHA_6R29GflvPwc9jngg_Y4GRQRHFMtU8KAKjYxsyHUn4-VsZGstCAzOG5Y_zSJuYFUWgWRLoNGO5yA1_QNbKqrSPCAVQAUAoizTy30MztUikDUNpjWZFHmQe2VzOqfrU0HaohqA5VDC6Sis3uh556ea7k9HnUzzplkTqZDJUBzvvd7kcDlTgkY2lQqjWyOeKgaAQHBTaIy-6x2CeuOeiS1vVIBPDd3jKuVglEwc8BaS6WiaVQsJq0SMPG4XsGh0KmeJKzyOvnFqt6rHa2xlvu6vH_yT9nFwbHY331f7bybsn5DrAxqg5ibdB1hbntX0K0GyRPXP29ws17TVc |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELaglRAceD8CBYxUcUHZJrGTONxautlS2NVSUdGb5cS2BLtNqm4iASf-ABK_kV_CjLMNLUIrwS1RJoofM5nP9sw3hGym4MMiHcagvCZ2Wze-iA33tVHWKHCAIcPc4fEk2Tvk-0fx0TI2B3NhOn6IfsMNLcP9r9HAT7Td-k0a-qk4HqgB4AfOL5N1ngD2RUx00LNHIVJ3h52wBPJZlCXL9Dx4snXu5QsOaR3H9vPf0OZF8Oq8T36jK7G6cKSFGHQyG7RNMSi__kHp-N8du0muL3Ep3e4U6Ra5ZKrb5No5tsI75Pu4hkmpQeOoqjSFtoB2gkIdu4N6Wn5p6hlIUyzDAr6R4g2SQFNMYaHTg1H-89uPYYWlTRpqMdWgootSWVvP9eIlHfa847S2FHAp7WJN8G5u2lkNHzD0Y1XOW9zhu0sO8-H7V3v-spqDXyYs5X4RBloENk5EplhgA60SE4UqFvDrNyLSJow0TBgWPy5jpZPQ2kCFaaCyIix5qdk9slbVlXlAKEAKgEFFrJD9HpqpeCpMFAmjVWjLoPDI5tmUypOOtEN29MyRhNGVSrrR9chzN929jDqdYZxbGssPk5Gc7rzbZWKUy8AjG2f6IJcmvpAhCHLOQJ098qx_DMaJJy6qMnULMgl8h2WM8VUyScAywKmrZTLBBawVPXK_08e-0REXGa7zPPLCadWqHsv9nfG2u3r4T9JPyZXpbi7fvp68eUSuAmaMuzC8DbLWnLbmMeCypnjirO8XdSQ0Cw |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Morphogen+and+proinflammatory+cytokine+release+kinetics+from+PRGF%E2%80%90Endoret+fibrin+scaffolds%3A+Evaluation+of+the+effect+of+leukocyte+inclusion&rft.jtitle=Journal+of+biomedical+materials+research.+Part+A&rft.au=Anitua%2C+E.&rft.au=Zalduendo%2C+M.+M.&rft.au=Prado%2C+R.&rft.au=Alkhraisat%2C+M.+H.&rft.date=2015-03-01&rft.issn=1549-3296&rft.eissn=1552-4965&rft.volume=103&rft.issue=3&rft.spage=1011&rft.epage=1020&rft_id=info:doi/10.1002%2Fjbm.a.35244&rft.externalDBID=n%2Fa&rft.externalDocID=10_1002_jbm_a_35244 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1549-3296&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1549-3296&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1549-3296&client=summon |